Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.365 USD | -1.82% |
|
-8.34% | -19.63% |
06-17 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
06-17 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.63% | 607M | |
+14.72% | 121B | |
+17.10% | 112B | |
+3.20% | 22.57B | |
-18.48% | 20.82B | |
-15.40% | 16.3B | |
-16.61% | 16.19B | |
-42.36% | 16.17B | |
+1.31% | 13.17B | |
+22.94% | 11.11B |
- Stock Market
- Equities
- ZYME Stock
- News Zymeworks Inc.
- Zymeworks Reports $50 Million Private Placement to EcoR1 Capital